The full form of EHT (medical), based on the provided reference, is Eicosanoyl-5-hydroxytryptamide.
Eicosanoyl-5-hydroxytryptamide (EHT) is a molecule that has shown potential in preventing Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid. This suggests it may have neuroprotective properties.
